Cantor's Dentice sees personalized medicine spurring M&A

The co-head of Cantor Fitzgerald's healthcare investment banking unit predicts that personalized medicine companies will become hot M&A targets for drugmakers and other life sciences companies.

More episodes of The Deal TV

Featured episodes in News & Politics

The Deal TV

Inside The Deal brings you the latest on business, the economy, mergers and acquisitions and dealmaking.